Non-PVC IV Bags Market Analysis By Type (Single Chamber, Multi Chamber), By Material (Ethylene Vinyl Acetate, Polypropylene, Copolyester Ether), By Content Type (Frozen Mixture, Liquid Mixture), And Segment Forecasts, 2014 - 2025

The global non-PVC IV bags market is expected to reach USD 2.29 billion by 2025, according to a new report by Grand View Research, Inc. Globally, increasing demand for safer medical packaging and strict regulations against usage of PVC are the key factors anticipated to boost the demand for non-PVC alternatives. Extensive research and developments for novel alternatives are expected to fuel the growth further.
As per the current market scenario, usage of non-PVC IV bags is limited to fields such as chemotherapy and parenteral nutrition. With the introduction of different types of alternatives such as ethylene vinyl acetate and polypropylene, PVC packaging is anticipated to be replaced by non-PVC alternatives. These materials can be used for specific purposes such as cold/frozen storage and customized mixtures. The non-PVC packaging market is expected to witness lucrative growth during the forecast period owing to the versatility of applications.
Demand for non-PVC plastics is increasing in medical as well as non-medical industries owing to stricter regulations against their usage since their disposal can cause high level of pollution. The changing trend of using non-PVC materials provides a huge scope for growth, thus attracting manufacturers and investors to this market.
The demand for non-PVC IV bags is increasing in parenteral nutrition services. They also have high demand for multichambered bags; as the formulation differs from patient to patient. The scope for customized IV bags providers is anticipated to increase with the development of personalized therapeutic solutions.
Further key findings from the report suggest:
‧ Single chamber bags dominated the market by capturing 64.6% of the total market share in 2016. High usage in IV drips and other mixtures is a principal factor that can be attributed to the large share.
‧ Ethylene vinyl acetate captured the largest share in 2016 and this dominance is expected to continue over the forecast period. Higher safety and utility of its usage in frozen mixtures including in blood banks are expected to have a high impact on the segment growth.
‧ The demand for copolyester ether is expected to showcase highest growth during the forecast period due to advantages such as transparency, durability, and chemical resistance.
‧ North America dominated the market and is expected to dominate throughout the forecast period. On the other hand, Asia Pacific is expected to showcase fastest growth, fueled by factors such as emergence of a large number of local players and increasing foreign direct investment.
‧ Key players include ANGIPLAST PVT. LTD.; RENOLIT; Shanghai Xin Gen Eco-Technologies Co., Ltd; PolyCine GmbH; Jiangxi Sanxin Medtec Co., Ltd.; Kraton Corporation; Pfizer, Inc. (Hospira).; Baxter; and B. Braun Melsungen AG

Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.2.1 Market formulation & validation
1.3 Region Wise Market Calculation
1.3.1 Region wise market: base estimates
1.4 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Non-PVC IV Bags Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Environment friendly nature of non-PVC IV bags
3.2.2 Increasing government initiatives
3.2.3 Increasing natality rate
3.2.4 Risk of malnutrition
3.2.5 Increasing incidence of cancer
3.3 Market Restraint Analysis
3.3.1 High cost of non-PVC IV bags
3.3.2 Stringent regulations
3.4 Penetration & Growth Prospect Mapping
3.5 Non-PVC IV Bags-SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis -Porter’s
3.7 Prospective Customers Outlook
Chapter 4 Non-PVC IV Bags Market: Type Estimates & Trend Analysis
4.1 Non-PVC IV Bags Market: Type Movement Analysis
4.2 Single Chamber
4.2.1 Single chamber market, 2014 - 2025 (USD Million)
4.3 Multichamber
4.3.1 Multichamber market, 2014 - 2025 (USD Million)
Chapter 5 Non-PVC IV Bags Market: Material Estimates & Trend Analysis
5.1 Non-PVC IV Bags Market: Material Movement Analysis
5.2 Ethylene vinyl acetate (EVA)
5.2.1 EVA market, 2014 - 2025 (USD Million)
5.3 Polypropylene
5.3.1 Polypropylene market, 2014 - 2025 (USD Million)
5.4 Copolyester Ether (COPE)
5.4.1 COPE market, 2014 - 2025 (USD Million)
5.5 Others
5.5.1 Others market, 2014 - 2025 (USD Million)
Chapter 6 Non-PVC IV Bags Market: Content Type Estimates & Trend Analysis
6.1 Non-PVC IV bags market: Content Type Movement Analysis
6.2 Frozen Mixture
6.2.1 Frozen mixture market, 2014 - 2025 (USD Million)
6.3 Liquid Mixture
6.3.1 Liquid mixture market, 2014 - 2025 (USD Million)
Chapter 7 Non-PVC IV Bag Market: Regional Estimates & Trend Analysis, by Type, Material, and Content Type
7.1 Non-PVC IV Bag Market Share By Region, 2016 & 2025
7.2 North America
7.2.1 North America non-PVC IV bag market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. non-PVC IV bag market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada non-PVC IV bag market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe non-PVC IV bag market, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK non-PVC IV bag market, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany non-PVC IV bag market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific non-PVC IV bag market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan non-PVC IV bag market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China non-PVC IV bag market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America non-PVC IV bag market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil non-PVC IV bag market, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico non-PVC IV bag market, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA non-PVC IV bag market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa non-PVC IV bag market, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Baxter
8.2.1.1 Company overview
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 B. Braun Melsungen AG
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 Pfizer, Inc. (Hospira)
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 Fresenius Kabi AG
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 JW Life Science
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 RENOLIT
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.4 Strategic initiatives
8.2.7 PolyCine GmbH
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.8 Sealed Air
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 Shanghai Xin Gen Eco-Technologies Co., Ltd.
8.2.9.1 Company overview
8.2.9.2 Product benchmarking
8.2.10 ANGIPLAST PVT. LTD.
8.2.10.1 Company overview
8.2.10.2 Product benchmarking
8.2.11 Shanghai Solve Care Co Ltd.
8.2.11.1 Company overview
8.2.11.2 Product benchmarking
8.2.12 Kraton Corporation
8.2.12.1 Company overview
8.2.12.2 Financial performance
8.2.12.3 Product benchmarking
8.2.12.4 Strategic initiatives
8.2.13 Jiangxi Sanxin Medtec Co., Ltd.
8.2.13.1 Financial performance
8.2.13.2 Product benchmarking